Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLL

Nishant Jindal,Deepesh Lad,Pankaj Malhotra,Gaurav Prakash,Alka Khadwal,Arihant Jain,Manupdesh Singh Sachdeva,Sreejesh Sreedharanunni,Shano Naseem,Neelam Varma,Subhash Varma

Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLL

2021

Nishant Jindal
Deepesh Lad
Pankaj Malhotra
Gaurav Prakash
Alka Khadwal
Arihant Jain
Manupdesh Singh Sachdeva
Sreejesh Sreedharanunni
Shano Naseem
Neelam Varma
Subhash Varma

Lenalidomide maintenance after frontline chemo-immunotherapy (CIT) in chronic lymphocytic leukemia (CLL) has not been standard due to the availability of novel therapies, though these remain out of...

Keywords:

chemo immunotherapy
Oncology
fixed duration
low dose
Internal medicine
Medicine
Chronic lymphocytic leukemia
Lenalidomide
Randomized controlled trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations